Quinazoline

Quinazoline

SCHEMBL28041229

C1CNC1.NC=O.c1ccc2ncncc2c1

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
EGFR P00533 9/20 0.62
PIK3CD O00329 1/20 0.44
PIK3CA P42336 1/20 0.44
CHRNB2 P17787 1/20 0.40
CHRNA4 P43681 1/20 0.40
TDO2 P48775 2/20 0.35
PDGFRB P09619 1/20 0.35
PDGFRA P16234 1/20 0.35
RAB9A P51151 1/20 0.34
NISCH Q9Y2I1 1/20 0.33
ALDH1A1 P00352 1/20 0.32
KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Quinazoline SCHEMBL27875528 0.90 EGFR (0.77) EGFRPIK3CDPIK3CACHRNB2CHRNA4
Quinazoline SCHEMBL1337802 0.90 EGFR (0.77) EGFRPIK3CDPIK3CATDO2PDGFRB
Quinazoline SCHEMBL29144630 0.87 EGFR (0.71) EGFRPIK3CDPIK3CACHRNB2CHRNA4
Quinazoline SCHEMBL6569237 0.85 EGFR (0.69) EGFRPIK3CDPIK3CACHRNB2CHRNA4
Quinazoline SCHEMBL16444698 0.83 EGFR (0.77) EGFRPIK3CDPIK3CACHRNB2CHRNA4
Quinazoline SCHEMBL3686138 0.83 EGFR (0.77) EGFRPIK3CDPIK3CACHRNB2CHRNA4
Quinazoline SCHEMBL29902476 0.80 EGFR (0.77) EGFRPIK3CDPIK3CATDO2PDGFRB
Quinazoline SCHEMBL5438273 0.80 EGFR (0.77) EGFRPIK3CDPIK3CATDO2PDGFRB
Quinazoline SCHEMBL27407620 0.79 EGFR (0.91) EGFRPIK3CDPIK3CATDO2PDGFRB
Quinazoline SCHEMBL29490398 0.79 EGFR (1.00) EGFRPIK3CDPIK3CATDO2PDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105939717-B Methods of treating and preventing alloantibody-driven chronic graft-versus-host disease 药品循环有限责任公司 2019-09-13 CN disclosed
CN-105939717-A Methods of treating and preventing alloantibody-driven chronic graft-versus-host disease 药品循环有限责任公司 2016-09-14 CN disclosed
CN-104994858-A TEC family kinase inhibitor adjuvant therapy PHARMACYCLICS INC 2015-10-21 CN disclosed